Researchers in China explored the impact of using TruScreen cervical cancer screening device in the absence of colposcopy and PAP facilities and commented on the…
Truscreen Group Limited (NZX and ASX:TRU) (TruScreen or Company) is pleased to announce the appointment of Dr. Dexter Cheung as a non-executive director of TruScreen.
Truscreen Limited's NZX Announcement dated 22 December 2020 advised that the Offer under the Product Disclosure Statement (PDS) lodged with the NZX on 11 November…
